Survival of mammalian B104 cells following neurite transection at different locations depends on somal Ca2+ concentration

J Neurobiol. 2004 Aug;60(2):137-53. doi: 10.1002/neu.20005.

Abstract

We report that cell survival after neurite transection in a mammalian neuronal model (cultured B104 cells) critically depends on somal [Ca2+]i, a novel result that reconciles separate long-standing observations that somal survival decreases with more-proximal axonal transections and that increased somal Ca2+ is cytotoxic. Using fluorescence microscopy, we demonstrate that extracellular Ca2+ at the site of plasmalemmal transection is necessary to form a plasmalemmal barrier, and that other divalent ions (Ba2+, Mg2+) do not play a major role. We also show that extracellular Ca2+, rather than injury per se, initiates the formation of a plasmalemmal barrier and that a transient increase in somal [Ca2+]i significantly decreases the percentage of cells that survive neurite transection. Furthermore, we show that the increased somal [Ca2+]i and decreased cell survival following proximal transections are not due to less frequent or slower plasmalemmal sealing or Ca2+ entry through plasmalemmal Na+ and Ca2+ channels. Rather, the increased somal [Ca2+]i and lethality of proximal neurite injuries may be due to the decreased path length/increased diameter for Ca2+ entering the transection site to reach the soma. A ryanodine block of Ca2+ release from internal stores before transection has no effect on cell survival; however, a ryanodine- or thapsigargin-induced buildup of somal [Ca2+]i before transection markedly reduces cell survival, suggesting a minor involvement of Ca2+-induced release from internal stores. Finally, we show that cell survival following proximal injuries can be enhanced by increasing intracellular Ca2+ buffering capacity with BAPTA to prevent the increase in somal [Ca2+]i.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cadmium / pharmacology
  • Calcium / metabolism*
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Cell Survival / physiology
  • Chelating Agents / pharmacology
  • Drug Interactions
  • Egtazic Acid / analogs & derivatives*
  • Egtazic Acid / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Fluorescent Dyes / metabolism
  • Intracellular Fluid / drug effects
  • Intracellular Fluid / metabolism*
  • Neurites / drug effects
  • Neurites / physiology*
  • Neuroblastoma
  • Neurons / drug effects
  • Neurons / physiology*
  • Potassium / pharmacology
  • Rats
  • Ryanodine / pharmacology
  • Thapsigargin / pharmacology
  • Time Factors
  • Trauma, Nervous System / pathology*

Substances

  • Chelating Agents
  • Enzyme Inhibitors
  • Fluorescent Dyes
  • Cadmium
  • Ryanodine
  • Egtazic Acid
  • Thapsigargin
  • 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid
  • Potassium
  • Calcium